Page 242 - The Memory Program How to Prevent Memory Loss and Enhance Memory Power
P. 242

Page 231


            Lemonick, M. D. Beyond depression. What do these “mood drugs’’really do? Time 153:74, May 17, 1999.
            Leo, M. A., Lieber, C. S. Alcohol, vitamin A, and beta -carotene: adverse interactions, including hepatotoxicity and
              carcinogenicity. American Journal of Clinical Nutrition 69:1071–1085, 1999.

            Letzel, H., Haan, J., Feil, W. B. Nootropics: efficacy and tolerability of products from three active substance classes.
              Journal of Drug Decision in Clinical Practice 8:77–94, 1996.

            Lipsky, P. E. The clinical potential of cyclooxygenase-2 inhibitors.  American Journal of Medicine 106 (5B):51S–57S,
              1999.

            Lissner, L., Bengtsson, C., Bjorkelund, C., Wedel, H. Physical activity levels and changes in relation to longevity. A
              prospective study of Swedish women. American Journal of Epidemiology  143:54–62, 1996.


            Loke, W. H. Effects of caffeine on mood and memory. Physiology and Behavior 44:367 –372, 1988.

            Lucca, U., Tettamanti, M., Forloni, G., Spagnoli, A. Nonsteroidal anti-inflammatory drug use in Alzheimer's disease.
              Biological Psychiatry 36:854–856, 1994.

            Lund-Manchester Group. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology,
              Neurosurgery and Psychiatry 57:416–418, 1994.

            Martzke, J. S., Kopala, L. C., Good, K. C. Olfactory disfunction in neuropsychiatric disorders: review and
              methodological considerations. Biological Psychiatry 42:721–732, 1997.

            Marwick, C. Growing use of medicinal botanicals forces assessment by drug regulators. Journal of the American Medical
              Association 273:607–609, 1995.

            Masuda, Y., Kokubu, T., Yamashita, M., Ikeda, H., Inoue, S. Egg phosphatidylcholine combined with vitamin B12
              improved memory impairment following lesioning of nucleus basalis in rats. Life Sciences 62:813 –822, 1998.


            Matthews, M. K. Association of ginkgo biloba with intracerebral hemorrhage. Neurology (letter) 50:1933 –1934, 1998.

            Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A., Hyman, B., et al. Utility of the apolipoprotein e
              genotype in the diagnosis of Alzheimer's disease. New England Journal of Medicine  338:506–511, 1998.

            Maylor, E. A., Rabbitt, P. M. Effect of alcohol on rate of forgetting. Psychopharmacology (Berlin) 91:230–235, 1987.

            McCleary, R., Dick, M. B., Buckwalter, G., Henderson, V. Full-information models for multiple psychometric tests:
              annualized rates of change in normal aging and dementia.  Alzheimer Disease and Associated Disorders 10:216–223,
              1996.

            McEwen, B. S. Permanence of brain sex differences and structural plasticity of the adult brain. Proceedings of the
              National Academy of Sciences 96:7128–7130, 1999.

            — — — Protective and damaging effects of stress mediators. New England Journal of Medicine  338:171–179, 1998.

            — — — Stress and hippocampal plasticity. Annual Review of Neuroscience 22:105–122, 1999.

            McEwen, B. S., Alves, S. E. Estrogen actions in the central nervous system. Endocrinology Review 20:279–307, 1999.

            McGeer, P. L., Schulzer, M., McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for
              Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425 –432, 1996.

            McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L, A., Salmon, D. P., et al. Consensus
              guidelines for the clinical and pathologic
   237   238   239   240   241   242   243   244   245   246   247